Immunonkologie bei Kopf-Hals-Tumoren-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunonkologie bei Kopf-Hals-Tumoren

Published:2021-12 Issue:04 Volume:3 Page:325-345
ISSN:2626-6628
Container-title:Onkologie up2date
language:de
Short-container-title:Onkologie up2date

Author:

Dietz Andreas¹,Stöhr Matthäus,Zebralla Veit,Pirlich Markus,Wichmann Gunnar,Wiegand Susanne

Affiliation:

1. Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Universität Leipzig, Leipzig, Deutschland

Publisher

Georg Thieme Verlag KG

Subject

General Medicine

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1587-2499.pdf

Reference32 articles.

1. Nivolumab for recurrent squamous-cell carcinoma of the head and neck;RL Ferris;N Engl J Med,2016

2. Platinum-based chemotherapy plus cetuximab in head and neck cancer;JB Vermorken;N Engl J Med,2008

3. KEYNOTE-048 investigators. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study;B Burtness;Lancet,2019

4. Oncology meets immunology: the cancer-immune cycle;DS Chen;Immunity,2013

5. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4;OS Qureshi;Science,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP